Charles Perou is a Professor of Genetics and Pathology at the University of North Carolina at Chapel Hill. Dr. Perou is known for his work in characterizing molecular subtypes of breast cancer, and his research involves using AI to understand cancer heterogeneity and biomarkers.His groundbreaking work has centered on molecular classification of breast cancer, where he identified distinct molecular subtypes with varying prognoses and treatment responses. Perou's pioneering research has shed light on the genetic and genomic factors that underlie these subtypes, leading to the discovery of important biomarkers that guide clinical decision-making. His efforts have not only advanced our understanding of cancer heterogeneity but have also paved the way for targeted therapies and personalized treatment approaches based on biomarker profiles.